US6352707B1
(en)
|
1992-02-24 |
2002-03-05 |
Anton-Lewis Usala |
Transplant encapsulation in a hydrogel matrix to obscure immune recognition
|
US6231881B1
(en)
|
1992-02-24 |
2001-05-15 |
Anton-Lewis Usala |
Medium and matrix for long-term proliferation of cells
|
US6334872B1
(en)
|
1994-02-18 |
2002-01-01 |
Organogenesis Inc. |
Method for treating diseased or damaged organs
|
EP0781114B1
(en)
*
|
1994-09-16 |
2005-05-25 |
Ethicon Endo-Surgery, Inc. |
Devices for defining and marking tissue
|
US6123727A
(en)
*
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
US6528483B2
(en)
|
1995-06-07 |
2003-03-04 |
André Beaulieu |
Method of producing concentrated non-buffered solutions of fibronectin
|
WO1998036705A1
(en)
|
1997-02-20 |
1998-08-27 |
Keller Gregory S |
Augmentation and repair of dermal, subcutaneous, and vocal cord tissue defects
|
US8288745B2
(en)
*
|
1997-10-10 |
2012-10-16 |
Senorx, Inc. |
Method of utilizing an implant for targeting external beam radiation
|
US8668737B2
(en)
|
1997-10-10 |
2014-03-11 |
Senorx, Inc. |
Tissue marking implant
|
DE69834836T2
(en)
*
|
1997-10-31 |
2007-05-16 |
Children's Medical Center Corp., Boston |
PENIS RECONSTRUCTION
|
DE69817863T2
(en)
*
|
1997-10-31 |
2004-07-15 |
Children's Medical Center Corp., Boston |
BLADDER RECONSTRUCTION
|
US6270464B1
(en)
|
1998-06-22 |
2001-08-07 |
Artemis Medical, Inc. |
Biopsy localization method and device
|
AU1588099A
(en)
*
|
1997-11-17 |
1999-06-07 |
Beth Israel Deaconess Medical Center |
Hybrid tissues for tissue engineering
|
US6872387B1
(en)
|
1998-02-24 |
2005-03-29 |
The Regents Of The University Of Michigan |
Three-dimensional hydrogel/cell system
|
US6660301B1
(en)
|
1998-03-06 |
2003-12-09 |
Biosphere Medical, Inc. |
Injectable microspheres for dermal augmentation and tissue bulking
|
EP1069822A1
(en)
*
|
1998-04-09 |
2001-01-24 |
Charlotte-Mecklenberg Hospital Authority |
Creation of three-dimensional tissues
|
US6171610B1
(en)
*
|
1998-04-24 |
2001-01-09 |
University Of Massachusetts |
Guided development and support of hydrogel-cell compositions
|
US6027744A
(en)
*
|
1998-04-24 |
2000-02-22 |
University Of Massachusetts Medical Center |
Guided development and support of hydrogel-cell compositions
|
DE69923674T2
(en)
*
|
1998-05-21 |
2005-12-29 |
Children's Medical Center Corp., Boston |
PENISRE CONSTRUCTION WITH THE HELP OF BODY TISSUE
|
US6224630B1
(en)
|
1998-05-29 |
2001-05-01 |
Advanced Bio Surfaces, Inc. |
Implantable tissue repair device
|
ATE423577T1
(en)
*
|
1998-06-05 |
2009-03-15 |
Organogenesis Inc |
BIOLOGICALLY MODELED IMPLANTABLE PROSTHESES
|
CA2334228C
(en)
*
|
1998-06-05 |
2010-09-28 |
Organogenesis Inc. |
Bioengineered vascular graft support prostheses
|
WO1999062425A2
(en)
*
|
1998-06-05 |
1999-12-09 |
Organogenesis Inc. |
Bioengineered vascular graft prostheses
|
CA2334364C
(en)
*
|
1998-06-05 |
2011-01-04 |
Organogenesis Inc. |
Bioengineered flat sheet graft prostheses
|
US20020058882A1
(en)
*
|
1998-06-22 |
2002-05-16 |
Artemis Medical, Incorporated |
Biopsy localization method and device
|
US6206930B1
(en)
|
1998-08-10 |
2001-03-27 |
Charlotte-Mecklenburg Hospital Authority |
Absorbable tissue expander
|
US6740122B1
(en)
|
1998-09-11 |
2004-05-25 |
C. R. Bard, Inc. |
Preformed curved prosthesis that is adapted to the external iliac vessels
|
US6723133B1
(en)
*
|
1998-09-11 |
2004-04-20 |
C. R. Bard, Inc. |
Performed curved prosthesis having a reduced incidence of developing wrinkles or folds
|
ATE311437T1
(en)
|
1998-09-18 |
2005-12-15 |
Massachusetts Inst Technology |
USE OF GROWTH FACTORS AND HORMONES TO PRODUCE HUMAN CHONDROCYTES AND CARTILAGE TISSUE PRODUCTION
|
EP2295540A1
(en)
*
|
1998-11-19 |
2011-03-16 |
Organogenesis, Inc. |
Bioengineered tissue constructs and methods for producing and using them
|
WO2000033771A2
(en)
*
|
1998-12-11 |
2000-06-15 |
Johnson Gerald W |
Implants filled with solid or semi-solid material
|
US9669113B1
(en)
|
1998-12-24 |
2017-06-06 |
Devicor Medical Products, Inc. |
Device and method for safe location and marking of a biopsy cavity
|
US6356782B1
(en)
|
1998-12-24 |
2002-03-12 |
Vivant Medical, Inc. |
Subcutaneous cavity marking device and method
|
US6371904B1
(en)
*
|
1998-12-24 |
2002-04-16 |
Vivant Medical, Inc. |
Subcutaneous cavity marking device and method
|
US6153432A
(en)
*
|
1999-01-29 |
2000-11-28 |
Zen-Bio, Inc |
Methods for the differentiation of human preadipocytes into adipocytes
|
US6197061B1
(en)
*
|
1999-03-01 |
2001-03-06 |
Koichi Masuda |
In vitro production of transplantable cartilage tissue cohesive cartilage produced thereby, and method for the surgical repair of cartilage damage
|
US20040167634A1
(en)
*
|
1999-05-26 |
2004-08-26 |
Anthony Atala |
Prosthetic kidney and its use for treating kidney disease
|
AU769853B2
(en)
*
|
1999-06-11 |
2004-02-05 |
Atossa Genetics, Inc. |
Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
|
US6521431B1
(en)
*
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US6783546B2
(en)
|
1999-09-13 |
2004-08-31 |
Keraplast Technologies, Ltd. |
Implantable prosthetic or tissue expanding device
|
US6371984B1
(en)
|
1999-09-13 |
2002-04-16 |
Keraplast Technologies, Ltd. |
Implantable prosthetic or tissue expanding device
|
US6592625B2
(en)
*
|
1999-10-20 |
2003-07-15 |
Anulex Technologies, Inc. |
Spinal disc annulus reconstruction method and spinal disc annulus stent
|
US7004970B2
(en)
|
1999-10-20 |
2006-02-28 |
Anulex Technologies, Inc. |
Methods and devices for spinal disc annulus reconstruction and repair
|
US8632590B2
(en)
|
1999-10-20 |
2014-01-21 |
Anulex Technologies, Inc. |
Apparatus and methods for the treatment of the intervertebral disc
|
US7615076B2
(en)
*
|
1999-10-20 |
2009-11-10 |
Anulex Technologies, Inc. |
Method and apparatus for the treatment of the intervertebral disc annulus
|
US20030153976A1
(en)
*
|
1999-10-20 |
2003-08-14 |
Cauthen Joseph C. |
Spinal disc annulus reconstruction method and spinal disc annulus stent
|
US7052516B2
(en)
*
|
1999-10-20 |
2006-05-30 |
Anulex Technologies, Inc. |
Spinal disc annulus reconstruction method and deformable spinal disc annulus stent
|
US20020123807A1
(en)
*
|
1999-10-20 |
2002-09-05 |
Cauthen Joseph C. |
Spinal disc annulus reconstruction method and spinal disc annulus stent
|
US8128698B2
(en)
|
1999-10-20 |
2012-03-06 |
Anulex Technologies, Inc. |
Method and apparatus for the treatment of the intervertebral disc annulus
|
US7935147B2
(en)
|
1999-10-20 |
2011-05-03 |
Anulex Technologies, Inc. |
Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus
|
US7951201B2
(en)
*
|
1999-10-20 |
2011-05-31 |
Anulex Technologies, Inc. |
Method and apparatus for the treatment of the intervertebral disc annulus
|
US7575921B2
(en)
*
|
1999-12-30 |
2009-08-18 |
Vbi Technologies, L.L.C. |
Spore-like cells and uses thereof
|
US7560275B2
(en)
*
|
1999-12-30 |
2009-07-14 |
Vbi Technologies, L.L.C. |
Compositions and methods for generating skin
|
US6436424B1
(en)
*
|
2000-03-20 |
2002-08-20 |
Biosphere Medical, Inc. |
Injectable and swellable microspheres for dermal augmentation
|
ATE327783T1
(en)
|
2000-03-20 |
2006-06-15 |
Biosphere Medical Inc |
INJECTABLE MICROBEADS FOR TISSUE BUILDING
|
US7338657B2
(en)
*
|
2001-03-15 |
2008-03-04 |
Biosphere Medical, Inc. |
Injectable microspheres for tissue construction
|
EP1274472A2
(en)
|
2000-03-20 |
2003-01-15 |
Biosphere Medical, Inc. |
Injectable and swellable microspheres for tissue bulking
|
WO2001072281A2
(en)
*
|
2000-03-24 |
2001-10-04 |
Biosphere Medical Inc. |
Microspheres for active embolization
|
US20030212022A1
(en)
*
|
2001-03-23 |
2003-11-13 |
Jean-Marie Vogel |
Compositions and methods for gene therapy
|
DE10026480A1
(en)
*
|
2000-05-29 |
2001-12-13 |
Augustinus Bader |
Method of making a recipient-specific tissue graft or implant
|
WO2001091773A2
(en)
|
2000-05-31 |
2001-12-06 |
Encelle, Inc. |
Method of stimulating hair growth
|
US6991652B2
(en)
*
|
2000-06-13 |
2006-01-31 |
Burg Karen J L |
Tissue engineering composite
|
US7998735B2
(en)
|
2000-08-21 |
2011-08-16 |
Victorian Tissue Engineering Centre Pty. Ltd. |
Vascularized tissue graft
|
JP2004505746A
(en)
*
|
2000-08-21 |
2004-02-26 |
バーナード オブライエン インスティチュート オブ マイクロサージェリー |
Vascularized tissue graft
|
CA2777791A1
(en)
*
|
2000-09-18 |
2002-03-21 |
Organogenesis Inc. |
Methods for treating a patient using a bioengineered flat sheet graft prostheses
|
WO2002057428A1
(en)
*
|
2000-10-30 |
2002-07-25 |
University Of Massachusetts |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
US20020142304A1
(en)
*
|
2001-03-09 |
2002-10-03 |
Anderson Daniel G. |
Uses and methods of making microarrays of polymeric biomaterials
|
US6656488B2
(en)
*
|
2001-04-11 |
2003-12-02 |
Ethicon Endo-Surgery, Inc. |
Bioabsorbable bag containing bioabsorbable materials of different bioabsorption rates for tissue engineering
|
DE10119522A1
(en)
*
|
2001-04-20 |
2002-12-05 |
Innovacell Biotechnologie Gmbh |
Preparation and application of a suspension composition with an ultrasound contrast medium
|
US7476257B2
(en)
|
2001-09-15 |
2009-01-13 |
Rush University Medical Center |
Methods to engineer stratified cartilage tissue
|
KR20030032420A
(en)
*
|
2001-10-18 |
2003-04-26 |
한국과학기술연구원 |
Porous Scaffold Made of Biodegradable Polymer for Reconstructing Damaged Ocular Tissue
|
US7722894B2
(en)
*
|
2001-10-22 |
2010-05-25 |
Massachusetts Institute Of Technology |
Biodegradable polymer
|
US20030165473A1
(en)
*
|
2001-11-09 |
2003-09-04 |
Rush-Presbyterian-St. Luke's Medical Center |
Engineered intervertebral disc tissue
|
AU2002340463A1
(en)
*
|
2001-11-16 |
2003-06-10 |
Children's Medical Center Corporation |
Augmentation of organ function
|
US20080086792A1
(en)
|
2006-10-13 |
2008-04-17 |
Thomas Charles Kuracina |
Method and apparatus for diverting sweat, liquid, moisture or the like from an eye
|
AU2003215330B2
(en)
|
2002-02-21 |
2008-03-13 |
Encelle, Inc. |
Immobilized bioactive hydrogel matrices as surface coatings
|
US7396537B1
(en)
*
|
2002-02-28 |
2008-07-08 |
The Trustees Of The University Of Pennsylvania |
Cell delivery patch for myocardial tissue engineering
|
CA2485259A1
(en)
*
|
2002-05-07 |
2003-11-20 |
Mcmaster University |
Microcapsules containing biomedical materials
|
US20040028804A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
US20050019747A1
(en)
*
|
2002-08-07 |
2005-01-27 |
Anderson Daniel G. |
Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
|
NZ538196A
(en)
|
2002-08-12 |
2007-05-31 |
Osteotech Inc |
Synthesis of a bone-polymer composite material for forming osteoimplants
|
US20040042997A1
(en)
*
|
2002-09-03 |
2004-03-04 |
Donnie Rudd |
Method of regenerating human tissue
|
US20040136968A1
(en)
*
|
2002-09-27 |
2004-07-15 |
Verigen Ag |
Autologous cells on a support matrix for tissue repair
|
WO2004034890A2
(en)
*
|
2002-10-17 |
2004-04-29 |
Vacanti, Joseph, P. |
Biological scaffolding material
|
KR100539371B1
(en)
*
|
2002-10-21 |
2005-12-27 |
메디칸(주) |
In vitro cultured human preadipocyte for human soft tissue volume replacement with injectable material as a scaffold
|
AU2003287444A1
(en)
*
|
2002-10-31 |
2004-05-25 |
The General Hospital Corporation |
Repairing or replacing tissues or organs
|
US9107751B2
(en)
*
|
2002-12-12 |
2015-08-18 |
Warsaw Orthopedic, Inc. |
Injectable and moldable bone substitute materials
|
CA2511486A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Angiotech International Ag |
Tissue reactive compounds and compositions and uses thereof
|
DE20306637U1
(en)
*
|
2003-04-28 |
2003-06-26 |
Gfe Medizintechnik Gmbh |
Soft tissue implants such as breast implants, calf muscle prosthesis or the like.
|
WO2005021737A1
(en)
|
2003-09-01 |
2005-03-10 |
Aivogen Ag |
Follicular fluid for prolonged growth and survival of cells for cell therapies
|
US7169180B2
(en)
*
|
2003-09-03 |
2007-01-30 |
Brennan William A |
System and method for breast augmentation
|
US8092527B2
(en)
*
|
2003-09-03 |
2012-01-10 |
Brennan William A |
System and method for breast augmentation
|
US20050136536A1
(en)
*
|
2003-09-15 |
2005-06-23 |
Anderson Daniel G. |
Embryonic epithelial cells
|
US7753955B2
(en)
*
|
2003-12-10 |
2010-07-13 |
Cellular Bioengineering, Inc. |
Methods and composition for soft tissue feature reconstruction
|
US8012210B2
(en)
*
|
2004-01-16 |
2011-09-06 |
Warsaw Orthopedic, Inc. |
Implant frames for use with settable materials and related methods of use
|
AU2005210630A1
(en)
*
|
2004-01-30 |
2005-08-18 |
Warsaw Orthopedic, Inc. |
Stacking implants for spinal fusion
|
US7351423B2
(en)
|
2004-09-01 |
2008-04-01 |
Depuy Spine, Inc. |
Musculo-skeletal implant having a bioactive gradient
|
US7273756B2
(en)
*
|
2004-10-01 |
2007-09-25 |
Isto Technologies, Inc. |
Method for chondrocyte expansion with phenotype retention
|
US8017394B2
(en)
*
|
2004-10-01 |
2011-09-13 |
Isto Technologies, Inc. |
Method for chondrocyte expansion with phenotype retention
|
US7235592B2
(en)
|
2004-10-12 |
2007-06-26 |
Zimmer Gmbh |
PVA hydrogel
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US7754241B1
(en)
|
2004-11-12 |
2010-07-13 |
Clemson University Research Foundation |
Macromonomer for preparation of a degradable hydrogel
|
AT501408B1
(en)
|
2004-12-07 |
2011-03-15 |
Physikalisches Buero Steinmueller Gmbh |
BIOLOGICAL SURFACES
|
ES2490610T3
(en)
*
|
2004-12-08 |
2014-09-04 |
Shire Regenerative Medicine, Inc. |
Materials and methods for minimally invasive administration of a fluid composition containing cells
|
US9788978B2
(en)
*
|
2004-12-20 |
2017-10-17 |
Nicholas A. Rojo |
Implantable systems and stents containing cells for therapeutic uses
|
US8017139B2
(en)
*
|
2005-02-23 |
2011-09-13 |
Zimmer Technology, Inc. |
Blend hydrogels and methods of making
|
ATE470701T1
(en)
*
|
2005-04-21 |
2010-06-15 |
Massachusetts Inst Technology |
MATERIALS AND METHODS FOR ALTERING AN IMMUNE RESPONSE TO EXOGENE AND ENDOGENE IMMUNOGENES, INCLUDING GENIDENTIC AND NON-GENIDENTIC CELLS, TISSUES OR ORGANS
|
AU2006245950B2
(en)
|
2005-05-09 |
2012-01-12 |
Biosphere Medical S.A. |
Compositions and methods using microspheres and non-ionic contrast agents
|
CN102743792B
(en)
|
2005-06-21 |
2014-09-24 |
夏尔再生医学公司 |
Methods and compositions for enhancing vascular access
|
WO2007022348A2
(en)
*
|
2005-08-18 |
2007-02-22 |
Massachusetts Institute Of Technology |
Amplification of cell polulations from embryonic stem cells
|
AU2006305989B2
(en)
|
2005-10-26 |
2013-10-24 |
Genesis Technologies Limited |
Acellular bioabsorbable tissue regeneration matrices produced by incubating acellular blood products
|
WO2007055882A2
(en)
*
|
2005-11-07 |
2007-05-18 |
Hosheng Tu |
Breast augmentation and reconstruction system
|
US20100204783A1
(en)
*
|
2005-12-06 |
2010-08-12 |
Helen Marie Nugent |
Methods and compositions for enhancing vascular access
|
AU2006321809A1
(en)
|
2005-12-07 |
2007-06-14 |
Zimmer, Inc. |
Methods of bonding or modifying hydrogels using irradiation
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
JP2007177244A
(en)
|
2005-12-22 |
2007-07-12 |
Zimmer Inc |
Perfluorocyclobutane crosslinked hydrogel
|
WO2007082304A2
(en)
|
2006-01-12 |
2007-07-19 |
Massachusetts Institute Of Technology |
Biodegradable elastomers
|
US20090011486A1
(en)
*
|
2006-01-12 |
2009-01-08 |
Massachusetts Institute Of Technology |
Biodegradable Elastomers
|
US8999933B2
(en)
*
|
2006-01-18 |
2015-04-07 |
Biolitec Pharma Marketing Ltd |
Photodynamic cosmetic procedure and healing method
|
EP1976459A4
(en)
*
|
2006-01-19 |
2012-06-20 |
Warsaw Orthopedic Inc |
Porous osteoimplant
|
US8110242B2
(en)
|
2006-03-24 |
2012-02-07 |
Zimmer, Inc. |
Methods of preparing hydrogel coatings
|
ES2776100T3
(en)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
System for targeted delivery of therapeutic agents
|
JP5630998B2
(en)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
Polymers for functional particles
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
US20080193536A1
(en)
*
|
2006-08-14 |
2008-08-14 |
Alireza Khademhosseini |
Cell-Laden Hydrogels
|
US7846728B2
(en)
*
|
2006-10-13 |
2010-12-07 |
BioStruxs, LLC |
Tissue engineering in vivo with vascularized scaffolds
|
CN103230414A
(en)
*
|
2006-11-07 |
2013-08-07 |
夏尔再生医学公司 |
Materials and methods for treating and managing angiogenesis-mediated diseases
|
WO2008147456A2
(en)
*
|
2006-11-20 |
2008-12-04 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
US8603524B2
(en)
*
|
2007-01-17 |
2013-12-10 |
Dow Agrosciences Llc |
Delivery of ethylene blocking and/or promoting agents
|
EP2134830A2
(en)
*
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
PT2136788E
(en)
|
2007-03-30 |
2012-02-03 |
Bind Biosciences Inc |
Cancer cell targeting using nanoparticles
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
JP2010523595A
(en)
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
Poly (amino acid) targeting part
|
WO2008144514A2
(en)
*
|
2007-05-17 |
2008-11-27 |
Massachusetts Institute Of Technology |
Polyol-based polymers
|
WO2008148026A1
(en)
*
|
2007-05-24 |
2008-12-04 |
The Trustees Of Columbia University In The City Of New York |
Hybrid soft tissue implants from progenitor cells and biomaterials
|
EP1997457B1
(en)
*
|
2007-06-01 |
2010-11-10 |
Allergan, Inc. |
Biological tissue growth support through induced tensile stress
|
CN103865871A
(en)
|
2007-06-08 |
2014-06-18 |
韦克福里斯特大学健康科学院 |
Selective cell therapy for the treatment of renal failure
|
US20100185156A1
(en)
*
|
2007-06-13 |
2010-07-22 |
Pervasis Therapeutics, Inc. |
Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions
|
US20080311177A1
(en)
|
2007-06-14 |
2008-12-18 |
Massachusetts Institute Of Technology |
Self Assembled Films for Protein and Drug Delivery Applications
|
US20100291219A1
(en)
*
|
2007-06-21 |
2010-11-18 |
Massachusetts Institute Of Technology |
Methods and compositions relating to progenitor cells
|
US7731988B2
(en)
*
|
2007-08-03 |
2010-06-08 |
Zimmer, Inc. |
Multi-polymer hydrogels
|
DE102007039871A1
(en)
|
2007-08-21 |
2009-02-26 |
Friedrich-Baur-Gmbh |
Soft tissue implant with antibacterial effect
|
US8062739B2
(en)
|
2007-08-31 |
2011-11-22 |
Zimmer, Inc. |
Hydrogels with gradient
|
US8293531B1
(en)
|
2007-08-31 |
2012-10-23 |
Clemson University Research Foundation |
Three-dimensional ex vivo system
|
US8697044B2
(en)
|
2007-10-09 |
2014-04-15 |
Allergan, Inc. |
Crossed-linked hyaluronic acid and collagen and uses thereof
|
WO2009051837A2
(en)
|
2007-10-12 |
2009-04-23 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
US7947784B2
(en)
|
2007-11-16 |
2011-05-24 |
Zimmer, Inc. |
Reactive compounding of hydrogels
|
AU2008331099B2
(en)
|
2007-11-26 |
2013-10-24 |
Collplant Ltd. |
Compositions comprising fibrous polypeptides and polysaccharides
|
US20090181104A1
(en)
*
|
2007-12-14 |
2009-07-16 |
Gino Rigotti |
Breast reconstruction or augmentation using computer-modeled deposition of processed adipose tissue
|
US8034362B2
(en)
|
2008-01-04 |
2011-10-11 |
Zimmer, Inc. |
Chemical composition of hydrogels for use as articulating surfaces
|
CA2719798A1
(en)
*
|
2008-03-28 |
2009-10-01 |
Osteotech, Inc. |
Bone anchors for orthopedic applications
|
ES2668398T3
(en)
*
|
2008-07-02 |
2018-05-17 |
Allergan, Inc. |
Compositions and procedures for tissue filling and regeneration
|
WO2010021973A2
(en)
*
|
2008-08-17 |
2010-02-25 |
Massachusetts Institute Of Technology |
Controlled delivery of bioactive agents from decomposable films
|
EP2349051A1
(en)
|
2008-08-20 |
2011-08-03 |
Allergan, Inc. |
Self-sealing shell for inflatable prostheses
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8343498B2
(en)
*
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8163022B2
(en)
|
2008-10-14 |
2012-04-24 |
Anulex Technologies, Inc. |
Method and apparatus for the treatment of the intervertebral disc annulus
|
CA2744100C
(en)
*
|
2008-10-21 |
2020-06-30 |
The General Hospital Corporation |
Cell transplantation
|
WO2010057015A1
(en)
*
|
2008-11-14 |
2010-05-20 |
Wake Forest University Health Sciences |
Kidney structures and methods of forming the same
|
WO2010057013A1
(en)
*
|
2008-11-14 |
2010-05-20 |
Wake Forest University Health Sciences |
Selective cell therapy for the treatment of renal failure
|
US9308070B2
(en)
|
2008-12-15 |
2016-04-12 |
Allergan, Inc. |
Pliable silk medical device
|
WO2010101628A2
(en)
|
2009-03-02 |
2010-09-10 |
Massachusetts Institute Of Technology |
Methods and products for in vivo enzyme profiling
|
US20100249924A1
(en)
*
|
2009-03-27 |
2010-09-30 |
Allergan, Inc. |
Bioerodible matrix for tissue involvement
|
US20110052695A1
(en)
*
|
2009-04-20 |
2011-03-03 |
Allergan, Inc. |
Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
|
US20110008406A1
(en)
*
|
2009-04-20 |
2011-01-13 |
Altman Gregory H |
Silk Fibroin Hydrogels and Uses Thereof
|
US20110189292A1
(en)
*
|
2009-04-20 |
2011-08-04 |
Allergan, Inc. |
Dermal fillers comprising silk fibroin hydrogels and uses thereof
|
US20110111031A1
(en)
*
|
2009-04-20 |
2011-05-12 |
Guang-Liang Jiang |
Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof
|
EA201890311A1
(en)
|
2009-05-27 |
2018-10-31 |
Селекта Байосайенсиз, Инк. |
POLYMERIC COMPOUNDS - IMMUNE MODULATING REMEDIES
|
US9014787B2
(en)
|
2009-06-01 |
2015-04-21 |
Focal Therapeutics, Inc. |
Bioabsorbable target for diagnostic or therapeutic procedure
|
KR20120059572A
(en)
|
2009-08-26 |
2012-06-08 |
셀렉타 바이오사이언시즈, 인크. |
Compositions that induce t cell help
|
US8795727B2
(en)
|
2009-11-09 |
2014-08-05 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
CN106913902A
(en)
|
2009-11-09 |
2017-07-04 |
聚光灯技术合伙有限责任公司 |
Polysaccharide based aquagel
|
IN2012DN05181A
(en)
|
2009-11-12 |
2015-10-23 |
Vbi Technologies Llc |
|
KR101812820B1
(en)
*
|
2010-01-08 |
2017-12-27 |
웨이크 포리스트 유니버시티 헬스 사이언시즈 |
Delivery system
|
US8652153B2
(en)
*
|
2010-01-11 |
2014-02-18 |
Anulex Technologies, Inc. |
Intervertebral disc annulus repair system and bone anchor delivery tool
|
PL2550027T5
(en)
|
2010-03-22 |
2019-07-31 |
Allergan, Inc. |
Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
|
KR20180099900A
(en)
|
2010-05-26 |
2018-09-05 |
셀렉타 바이오사이언시즈, 인크. |
Dose selection of adjuvanted synthetic nanocarriers
|
BR112013002859B1
(en)
|
2010-08-06 |
2020-10-06 |
The General Hospital Corporation D/B/A Massachusetts General Hospital |
METHOD AND APPARATUS FOR CELL TREATMENT
|
US8926963B2
(en)
|
2010-08-19 |
2015-01-06 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8741281B2
(en)
|
2010-08-19 |
2014-06-03 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
EP2605762A1
(en)
|
2010-08-19 |
2013-06-26 |
Allergan, Inc. |
Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition
|
US8900571B2
(en)
|
2010-08-19 |
2014-12-02 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8697057B2
(en)
|
2010-08-19 |
2014-04-15 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8894992B2
(en)
|
2010-08-19 |
2014-11-25 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US9549901B2
(en)
|
2010-09-03 |
2017-01-24 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
KR101983402B1
(en)
|
2011-03-07 |
2019-05-28 |
웨이크 포리스트 유니버시티 헬스 사이언시즈 |
Delivery system
|
PT3199126T
(en)
|
2011-03-09 |
2020-01-28 |
Tepha Inc |
Systems for mastopexy
|
US9289476B2
(en)
|
2011-04-29 |
2016-03-22 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers for allergy therapy
|
US8753309B2
(en)
|
2011-06-24 |
2014-06-17 |
The Invention Science Fund I, Llc |
Device, system, and method including micro-patterned cell treatment array
|
CN102258810A
(en)
*
|
2011-07-20 |
2011-11-30 |
王泰华 |
Preparation method of adipose tissue breast augmentation material enriched with autologous stem cells
|
US20130039954A1
(en)
|
2011-07-29 |
2013-02-14 |
Selecta Biosciences, Inc. |
Control of antibody responses to synthetic nanocarriers
|
EP2742134A2
(en)
|
2011-08-11 |
2014-06-18 |
Qiagen GmbH |
Cell- or virus simulating means comprising encapsulated marker molecules
|
EP2776052B1
(en)
|
2011-11-02 |
2017-06-14 |
Halscion, Inc. |
Methods and compositions for wound treatment
|
ES2705823T3
(en)
*
|
2012-01-24 |
2019-03-26 |
Lifecell Corp |
Matrices of elongated tissues
|
WO2013163234A1
(en)
|
2012-04-23 |
2013-10-31 |
Massachusetts Institute Of Technology |
Stable layer-by-layer coated particles
|
US20130289389A1
(en)
|
2012-04-26 |
2013-10-31 |
Focal Therapeutics |
Surgical implant for marking soft tissue
|
US20140017263A1
(en)
|
2012-06-28 |
2014-01-16 |
Clemson University |
Delivery Agents for Targeted Treatment of Elastin Degradation
|
WO2014039995A1
(en)
|
2012-09-07 |
2014-03-13 |
Fibrocell Technologies, Inc. |
Fibroblast compositions for treating cardial damage after an infarct
|
EP2948068A4
(en)
|
2013-01-28 |
2016-09-28 |
Cartiva Inc |
Systems and methods for orthopedic repair
|
US9737294B2
(en)
|
2013-01-28 |
2017-08-22 |
Cartiva, Inc. |
Method and system for orthopedic repair
|
WO2014134029A1
(en)
|
2013-02-26 |
2014-09-04 |
Massachusetts Institute Of Technology |
Nucleic acid particles, methods and use thereof
|
WO2014164815A2
(en)
|
2013-03-12 |
2014-10-09 |
Allergan, Inc. |
Adipose tissue combinations, devices, and uses thereof
|
EA201591761A1
(en)
|
2013-03-14 |
2016-03-31 |
Президент Энд Феллоуз Оф Гарвард Колледж |
COMPOSITIONS BASED ON NANOPARTICLES
|
WO2014150074A1
(en)
|
2013-03-15 |
2014-09-25 |
Massachusetts Institute Of Technology |
Compositions and methods for nucleic acid delivery
|
WO2014179772A2
(en)
|
2013-05-03 |
2014-11-06 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen
|
US20140350516A1
(en)
|
2013-05-23 |
2014-11-27 |
Allergan, Inc. |
Mechanical syringe accessory
|
CN112933218A
(en)
|
2013-06-04 |
2021-06-11 |
西莱克塔生物科技公司 |
Repeated administration of non-immunosuppressive antigen-specific immunotherapeutics
|
AU2014286999B2
(en)
|
2013-07-11 |
2017-04-13 |
Tepha, Inc. |
Absorbable implants for plastic surgery
|
CN104278008B
(en)
|
2013-07-12 |
2020-08-21 |
北京宏冠再生医学科技有限公司 |
Method, kit and application for preparing pluripotent stem cells through small molecule compound treatment
|
US9795573B2
(en)
|
2013-09-24 |
2017-10-24 |
Clemson University |
Multi-step connective tissue stabilization method and stabilized tissue formed thereby
|
US9248384B2
(en)
|
2013-10-02 |
2016-02-02 |
Allergan, Inc. |
Fat processing system
|
US10159765B2
(en)
|
2013-10-25 |
2018-12-25 |
The Board Of Regents Of The University Of Texas System |
Tissue engineered devices and methods for making same
|
US10029048B2
(en)
|
2014-05-13 |
2018-07-24 |
Allergan, Inc. |
High force injection devices
|
GB2526542A
(en)
*
|
2014-05-26 |
2015-12-02 |
David Anthony Waghorn |
Stem cell implanter and absorbable stem cell implant
|
US11638640B2
(en)
|
2014-06-11 |
2023-05-02 |
Bard Shannon Limited |
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
|
US11883275B2
(en)
|
2014-06-11 |
2024-01-30 |
Bard Shannon Limited |
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
|
WO2015200728A1
(en)
|
2014-06-25 |
2015-12-30 |
Selecta Biosciences, Inc. |
Methods and compositions for treatment with synthetic nanocarriers and immune checkpoint inhibitors
|
JP6702635B2
(en)
|
2014-07-25 |
2020-06-03 |
フォーカル セラピューティクス,インコーポレイテッド |
Implantable devices and techniques for oncoplastic surgery
|
WO2016037165A1
(en)
|
2014-09-07 |
2016-03-10 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating exon skipping anti-viral transfer vector immune responses
|
EP2995278A1
(en)
*
|
2014-09-09 |
2016-03-16 |
Klinikum rechts der Isar der Technischen Universität München |
Medical/surgical implant
|
WO2016073798A1
(en)
|
2014-11-05 |
2016-05-12 |
Selecta Biosciences, Inc. |
Methods and compositions related to the use of low hlb surfactants in the production of synthetic nanocarriers comprising a rapalog
|
US10433928B2
(en)
|
2015-03-10 |
2019-10-08 |
Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company |
Multiple needle injector
|
USD803401S1
(en)
|
2015-04-23 |
2017-11-21 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
US11028369B2
(en)
|
2015-08-13 |
2021-06-08 |
Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. |
Induced extended pluripotent stem cells, method of making and using
|
AR106018A1
(en)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
|
ES2908479T3
(en)
|
2015-08-26 |
2022-04-29 |
Achillion Pharmaceuticals Inc |
Compounds for the treatment of immune and inflammatory disorders
|
USD836778S1
(en)
|
2015-10-09 |
2018-12-25 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
US20190282624A1
(en)
|
2015-11-30 |
2019-09-19 |
Beihao Stem Cell And Regenerative Medicine Research Institute Co., Ltd. |
Improved methods for reprograming non-pluripotent cells into pluripotent stem cells
|
WO2017117188A1
(en)
|
2015-12-29 |
2017-07-06 |
Massachusetts Institute Of Technology |
Biodegradable free-standing controlled drug release stickers
|
EP3416686A1
(en)
|
2016-02-16 |
2018-12-26 |
Dana Farber Cancer Institute, Inc. |
Immunotherapy compositions and methods
|
KR20220123332A
(en)
|
2016-03-11 |
2022-09-06 |
셀렉타 바이오사이언시즈, 인크. |
Formulations and doses of pegylated uricase
|
KR102288170B1
(en)
|
2016-04-08 |
2021-08-09 |
알레간 인코포레이티드 |
Aspiration and injection device
|
ES2902006T3
(en)
|
2016-06-27 |
2022-03-24 |
Achillion Pharmaceuticals Inc |
Quinazoline and indole compounds to treat medical disorders
|
US20180085319A1
(en)
|
2016-09-27 |
2018-03-29 |
Takashi Kei Kishimoto |
Methods and compositions for treating cancer
|
EP3541391A4
(en)
|
2016-11-17 |
2020-06-17 |
The University of North Carolina at Chapel Hill |
Alkyl pyrrolopyrimidine analogs and methods of making and using same
|
CA3049384A1
(en)
|
2017-01-07 |
2018-07-12 |
Selecta Biosciences, Inc. |
Patterned dosing of immunosuppressants coupled to synthetic nanocarriers
|
KR20190124295A
(en)
|
2017-03-11 |
2019-11-04 |
셀렉타 바이오사이언시즈, 인크. |
Methods and compositions related to combination treatment with synthetic nanocarriers comprising anti-inflammatory agents and immunosuppressants
|
EP3607085A1
(en)
|
2017-04-07 |
2020-02-12 |
Massachusetts Institute Of Technology |
Methods to spatially profile protease activity in tissue and sections
|
USD816220S1
(en)
|
2017-04-11 |
2018-04-24 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
USD816221S1
(en)
|
2017-04-11 |
2018-04-24 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
CN110832069B
(en)
|
2017-05-31 |
2023-06-20 |
北昊干细胞与再生医学研究院有限公司 |
Methods for chemically induced lineage reprogramming
|
CA3070468A1
(en)
|
2017-09-01 |
2019-03-07 |
Dana-Farber Cancer Institute, Inc. |
Immunogenic peptides specific to bcma and taci antigens for treatment of cancer
|
US11219502B2
(en)
|
2017-09-11 |
2022-01-11 |
Medtronic Advanced Energy, Llc |
Transformative shape-memory polymer tissue cavity marker devices, systems and deployment methods
|
WO2019075292A1
(en)
|
2017-10-12 |
2019-04-18 |
Massachusetts Institute Of Technology |
Prostate cancer protease nanosensors and uses thereof
|
CN111542336A
(en)
|
2017-10-13 |
2020-08-14 |
西莱克塔生物科技公司 |
Methods and compositions for attenuating antiviral transfer vector IGM response
|
DE102017009989A1
(en)
|
2017-10-26 |
2019-05-02 |
Carl Freudenberg Kg |
Biocompatible composite for insertion into a human body
|
WO2019089567A1
(en)
|
2017-10-30 |
2019-05-09 |
Massachusetts Institute Of Technology |
Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
|
WO2019104392A1
(en)
*
|
2017-11-30 |
2019-06-06 |
Queensland University Of Technology |
Modular tissue implants
|
US11324567B2
(en)
|
2018-02-01 |
2022-05-10 |
Medtronic Advanced Energy, Llc |
Expandable tissue cavity marker devices, systems and deployment methods
|
USD889655S1
(en)
|
2018-02-09 |
2020-07-07 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
USD889654S1
(en)
|
2018-02-09 |
2020-07-07 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
WO2019156870A2
(en)
|
2018-02-09 |
2019-08-15 |
Tepha, Inc. |
Full contour breast implant
|
US11054428B2
(en)
|
2018-03-05 |
2021-07-06 |
Massachusetts Institute Of Technology |
Inhalable nanosensors with volatile reporters and uses thereof
|
US11844682B2
(en)
|
2018-03-12 |
2023-12-19 |
Bard Shannon Limited |
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material
|
US20210115378A1
(en)
|
2018-05-09 |
2021-04-22 |
Yale University |
Compositions and systems for ex vivo cell modulation and methods of use thereof
|
USD892329S1
(en)
|
2018-07-03 |
2020-08-04 |
Tepha, Inc. |
Three dimensional mastopexy implant
|
WO2020018583A1
(en)
|
2018-07-16 |
2020-01-23 |
Selecta Biosciences, Inc. |
Methods and compositions of otc constructs and vectors
|
MX2021000638A
(en)
|
2018-07-16 |
2021-06-23 |
Selecta Biosciences Inc |
Methods and compositions of mma constructs and vectors.
|
US20230022157A1
(en)
|
2018-08-20 |
2023-01-26 |
Achillion Pharmaceuticals, Inc. |
Pharmaceutical compounds for the treatment of complement factor d medical disorders
|
US20200096514A1
(en)
|
2018-09-25 |
2020-03-26 |
Massachusetts Institute Of Technology |
Lung protease nanosensors and uses thereof
|
CA3109394A1
(en)
|
2018-10-02 |
2020-04-09 |
Tepha, Inc. |
Medical devices to limit movement of breast implants
|
US20200116725A1
(en)
|
2018-10-16 |
2020-04-16 |
Massachusetts Institute Of Technology |
Renal clearable nanocatalysts for disease monitoring
|
WO2020081723A1
(en)
|
2018-10-16 |
2020-04-23 |
Georgia State University Research Foundation, Inc. |
Carbon monoxide prodrugs for the treatment of medical disorders
|
US11835522B2
(en)
|
2019-01-17 |
2023-12-05 |
Massachusetts Institute Of Technology |
Sensors for detecting and imaging of cancer metastasis
|
EP3962537A1
(en)
|
2019-04-28 |
2022-03-09 |
Selecta Biosciences, Inc. |
Methods for treatment of subjects with preexisting immunity to viral transfer vectors
|
EP3976802A1
(en)
|
2019-05-28 |
2022-04-06 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuated anti-viral transfer vector immune response
|
US20200399628A1
(en)
|
2019-06-04 |
2020-12-24 |
Selecta Biosciences, Inc. |
Formulations and doses of pegylated uricase
|
JP2022553345A
(en)
|
2019-10-21 |
2022-12-22 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
Methods and compositions for treating liver disease and disorders
|
JP2023501457A
(en)
|
2019-11-08 |
2023-01-18 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
Formulation and dosage of pegylated uricase
|
EP4065043A1
(en)
|
2019-11-25 |
2022-10-05 |
Tepha, Inc. |
Breast implant wraps to limit movement of breast implants and related methods
|
US20210262025A1
(en)
|
2020-02-18 |
2021-08-26 |
Massachusetts Institute Of Technology |
Multiplexed in vivo disease sensing with nucleic acid-barcoded reporters
|
EP4110334A1
(en)
|
2020-02-26 |
2023-01-04 |
Selecta Biosciences, Inc. |
Methods and compositions using synthetic nanocarriers comprising immunosuppressant
|
CN115484931A
(en)
|
2020-03-11 |
2022-12-16 |
西莱克塔生物科技公司 |
Methods and compositions related to synthetic nanocarriers
|
BR122023021708A2
(en)
|
2020-03-23 |
2024-02-20 |
Bard Shannon Limited |
IMPLANTABLE PROSTHESIS COMPRISING BIOCOMPATIBLE MATERIAL STRUCTURE
|
CN115698262A
(en)
|
2020-03-30 |
2023-02-03 |
阿卜杜拉国王科技大学 |
Compositions and methods for controlling cell identity
|
US20230147052A1
(en)
|
2020-04-14 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for inducing autophagy
|
US11413129B2
(en)
|
2020-06-19 |
2022-08-16 |
Davol Inc. |
Implantable prosthesis
|
US20220133864A1
(en)
|
2020-11-04 |
2022-05-05 |
Selecta Biosciences, Inc. |
Methods and compositions for reducing immune responses against immunoglobulin proteases
|
CA3207247A1
(en)
|
2021-01-05 |
2022-07-14 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
JP2024514577A
(en)
|
2021-04-09 |
2024-04-02 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
Synthetic nanocarriers containing immunosuppressants in combination with high affinity IL-2 receptor agonists to enhance immune tolerance
|
EP4337694A1
(en)
|
2021-05-12 |
2024-03-20 |
Dana-Farber Cancer Institute, Inc. |
Lag3 and gal3 inhibitory agents, xbp1, cs1, and cd138 peptides, and methods of use thereof
|
WO2023064350A1
(en)
|
2021-10-12 |
2023-04-20 |
Selecta Biosciences, Inc. |
Viral vector dosing protocols
|
US20230141563A1
(en)
|
2021-10-12 |
2023-05-11 |
Selecta Biosciences, Inc. |
Methods and compositions for attenuating anti-viral transfer vector igm responses
|
WO2023086615A1
(en)
|
2021-11-14 |
2023-05-19 |
Selecta Biosciences, Inc. |
Multiple dosing with viral vectors
|
US20230263906A1
(en)
|
2022-01-10 |
2023-08-24 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and synthetic nanocarrier dose sparing
|
US20230357437A1
(en)
|
2022-03-09 |
2023-11-09 |
Selecta Biosciences, Inc. |
Immunosuppressants in combination with anti-igm agents and related dosing
|
WO2023172628A1
(en)
|
2022-03-09 |
2023-09-14 |
Selecta Biosciences, Inc. |
Immunosuppressant in combination with high affinity il-2 receptor agonists and related dosing
|
US20230372535A1
(en)
|
2022-03-25 |
2023-11-23 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising an immunosuppressant in combination with high affinity il-2 receptor agonists and anti-igm agents
|
WO2023196566A1
(en)
|
2022-04-08 |
2023-10-12 |
Selecta Biosciences, Inc. |
High affinity il-2 receptor agonists and immunosuppressants to enhance immune tolerance
|
CN114748689B
(en)
*
|
2022-04-14 |
2023-09-15 |
华南理工大学 |
Mammary gland reconstruction implant prosthesis hydrogel material and preparation method and application thereof
|
WO2024036324A1
(en)
|
2022-08-11 |
2024-02-15 |
Selecta Biosciences, Inc. |
Compositions and methods related to immunoglobulin proteases and fusions thereof
|